Cheng Ean Chee

9PUBLICATIONS

74CO-AUTHORS

Molecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 25, 2026

Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Aug 01, 2025

Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024.

Giang Le Minh, Sasidharan Swarnalatha Lucky, Shazib Pervaiz

|May 20, 2024

State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.

Priyadarshini S Pathak, Gloria Chan, Dustin A Deming

|Apr 15, 2023

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Cheng E Chee, Melissa Ooi, Soo-Chin Lee

|Feb 16, 2023

Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.

Jerold Loh, Jiaxuan Wu, Jenny Chieng

|Apr 01, 2022

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

Joline S J Lim, Andrea L A Wong, Samuel G W Ow

Pageof 2

Frequent Collaborators

Raghav Sundar

Lingzhi Wang

Pinelopi Andrikakou

Tim Meyer

Kai-Wen Huang

Soo-Chin Lee

Wei Peng Yong

Bristi Basu

Joline S J Lim

Robert Habib

Frequent Collaborators

Raghav Sundar

Lingzhi Wang

Pinelopi Andrikakou

Tim Meyer